Medical decision analysis : an application in hypertension. by Kapernick, Robert Edwin
MEDICAL DECISION ANALYSIS —








it H I i




* C *J 'W 8m
I 4
MEDICAL DECISION ANALYSIS




Thesis Advi sor t y r
I 3WI*mCC^¥%*JW
Approved for public release; distribution unlimited.
T167533






2. GOVT ACCESSION NO 3. RECIPIENT'S CATALOG NUMBER
TITLE (and Subtitle)
Medical Decision Analysis—
An Application in Hypertension
5. TYPE OF REPORT ft PERIOD COVERED
Master's Thesis
March 1975
• • t-E*FOKMING OHC. REPORT NUMBER
AUTHORS
Robert Edwin Kapernick
6 CONTRACT OR CKAnT NUMSERfa;
9- PERFORMING ORGANIZATION NAME AND ADDRESS
Naval Postgraduate School
Monterey, California 93940
io. ppogram element, project, tasc
AREA ft WORK UKlT NUMBERS





13. NUMBER OF PAGES
TIT MONITORING AGENCY NAME ft ADDRESSfl/ different from Controlling Office)
Naval Postgraduate School
Monterey, California 93940
15. SECURITY CLASS, (of thie report)
Unclassified
15a. DECL ASS! PI CATION/ DOWN GRADING
SCHEDULE
16. DISTRIBUTION ST ATEMENT (of thi* Report)
Approved for public release; distribution unlimited.
17. DISTRIBUTION STATEMENT (of the abetract entered In Block 20. It different from Report)
18. SUPPLEMENTARY NOTES
19. KEY WORDS (Continue on reveree aide II neceeeery and Identity by block number)
20. ABSTRACT ,'Coniinut on reveree elde It neceeeery and Identity by block number)
A decision analysis was conducted on the specific diagnostic category
of hypertension to obtain optimal diagnosis -treatment procedures. Emphasis
was placed on the problem formulation phase of the decision analysis.
Twelve categories of sustained diastolic hypertensive patiencs were selected?
for problem formulation. The problem formulation had three diagnosis-
treatment strategies: conduct laboratory tests to investigate for surgically!






EDITION OF 1 NOV 65 IS OBSOLETE
S/N 0102-014- 6601 I
1 SECURITY CLASSIFICATION OF THIS PACE (When Date
Knitted)

i*fcCU«*1TY CLASSIFICATION OF THIS PUGECH^nn D*f« Enfrmd-
The problem solution phase of the decision analysis was conducted in
the environment of a military installation where the government was the
sole provider. Three patient decision-makers, representing six of the
twelve total patient categories, were used to analyze the three diagnosis-
treatment strategies. Decision analysis results were intuitive, giving








2 SECURITY CLASSIFICATION OF T H IS PAGEr**"" D»f Ent«'«dj

Medical Decision Analysis ~
An Application in Hypertension
by
Robert Edwin Kapernick
Lieutenant, United States Navy
B.S., Montana State University, 1965
Submitted in partial fulfillment of the
requirements for the degree of








A decision analysis was conducted on the specific diagnostic cate-
gory of hypertension to obtain optimal diagnosis-treatment procedures.
Emphasis was placed on the problem formulation phase of the decision
analysis. Twelve categories of sustained diastolic hypertensive
patients were selected for problem formulation. The problem formula-
tion had three diagnosis -treatment strategies: conduct laboratory tests
to investigate for surgically correctable causes of hypertension,
administer drugs to treat hypertension, and do nothing.
The problem solution phase of the decision analysis was conducted
in the environment of a military installation where the government was
the sole provider. Three patient dec is ion-makers, representing six of
the twelve total patient categories, were used to analyze the three
diagnosis-treatment strategies. Decision analysis results were in-
tuitive, giving credence to the hypertension problem formulation and
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I. INTRODUCTION
In recent years decision problems in medicine have become increas-
ingly important because of rapidly expanding technology and higher
risks in terms of money and human life. A medical problem of funda-
mental importance is determining proper diagnosis-treatment procedures
for specific diagnostic categories. Medical training is traditionally
along the lines of specific diseases, their symptoms and their treat-
ments. However, little training is given for considering the uncer-
tainty in the diagnosis and the effect of that uncertainty upon the
treatment. Another difficulty in treating specific diagnostic cate-
gories is the complexity of the issues involved. Doctors must often
choose between a number of conflicting factors and try to reach deci-
sions with little cost and probability data to aid them.
Decision analysis is a rational, systematic approach that allows
one to cope with problem uncertainties and complexities. These attri-
butes make decision analysis an attractive method for obtaining optimal
diagnosis-treatment procedures in specific diagnostic categories.
A. PURPOSES
The purposes of this thesis are three- fold. The first purpose is
to demonstrate that decision analysis can be used to obtain optimal
diagnosis -treatment procedures in specific diagnostic categories. The
second purpose is to provide the author with experience in conducting a
decision analysis. The third purpose is to generate interest in the
use of decision analysis in medical dec is ion-making.

B. HYPERTENSION
A specific diagnostic category where diagnosis treatment procedures
are particularly controversial is hypertension. The lack of standardi-
zation in diagnosing and treating hypertension, and the high incidence
of hypertension among the general public makes the specific category of
hypertension an attractive candidate for decision analysis.
C. THESIS ORGANIZATION
This thesis is organized in the following manner. Chapter II pro-
vides decision analysis methodology necessary to solve the hypertension
problem. Chapter III develops the medical background of hypertension
and discusses possible test and treatment alternatives. Chapter IV
formulates the hypertension problem. This formulation consists of
structuring diagnosis -treatment alternatives so that problem uncertain-
ties and complexities can be analyzed. Chapter V solves the hyperten-
sion problem and discusses solution results.
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II. DECISION ANALYSES OF SPECIFIC DIAGNOSTIC CATEGORIES
Decision analysis is a rational, systematic technique well-suited
for cclving complex and uncertain problems. Recently, there has been
an increase in applying decision analysis to medical problems. Among
the reasons for this are: medical decisions have important conse-
quences in cost, suffering, and death; medical problems are complex
and involve uncertainty; and public interest in medicine is high [1],
A "number of articles describe the application of decision analysis to
medical problems. In particular, decision analysis has been fruit-
fully applied to severe abdominal pain, acute renal failure, and the
sore-throat problem [2].
This paper proposes that decision analyses of specific diagnostic
categories are a viable means of obtaining substantive diagnosis-
treatment procedures. Based on the successful application of decision
analysis to medical problems in the past, additional analyses should
be undertaken to provide a richer reservoir of optimal treatment
procedures
.
This chapter is divided into two parts. Section A gives a brief
discussion of problem characteristics that cause complexities in formal
analyses and establishes which of these characteristics occur when
evaluating diagnostic categories. The majority of the chapter is
devoted to Section B where the methodology for decision analysis is





"Real-life" problems have varying degrees of complexity. Giauque
[1] states that a problem can be:
1. well-defined or ill-defined,
2. treated as certain or uncertain, and
3. single attributed or multiattributed.
Ill-defined problems are cases where decision alternatives and the
consequences of these alternatives are poorly understood. In these
situations, effort is required to define critical questions, options,
and relevant considerations before the problem can be meaningfully
discussed. Uncertainty occurs when the exact value of the result for
a decision alternative is unknown; however, for any given alternative,
some results are more likely than others. Multiattributed problems
have more than one important consequence that must be considered when
evaluating each decision alternative. A decision-maker must either
implicitly or explicitly make trade-offs among these consequences
when evaluating each alternative. The complexity of a problem depends
on the degree to which it is ill-defined, uncertain, and multi-
attributed.
The problem of evaluating specific diagnostic categories for proper
diagnosis -treatment procedures is essentially well-defined. The alter-
natives and the consequences that can occur as a result of these alter-
natives are usually known. This point can be illustrated by using the
example of the standard sore-throat problem. The fundamental treatment
alternatives are to either prescribe an antibiotic or do nothing. The
possible consequences for either of these alternatives can be logically
12

divided into factors related to cost (e.g., cost of medicine to the
patient or cost of lost time if the patient becomes ill) and factors
related to health (e.g., patient incurring strep throat or patient
experiencing a drug reaction) . Although there is more than one
possible alternative and although each alternative has several conse-
quences, the physician is usually cognizant of these alternatives and
consequences
.
Specific diagnostic categories, however, are complicated by both
a need to allow for multiple outcomes and the need to allow for uncer-
tainty in diagnostic and treatment procedures. Returning to the sore-
throat problem, uncertainty occurs because the exact result for either
alternative is not known. Some patients will derive very little bene-
fit from an antibiotic, while others are markedly improved. And in
an extreme case, a patient can incur a violent drug reaction and
possibly die. The problem is multiattributed in the sense that the
doctor is confronted with several measures of patient welfare which
must be simultaneously considered for each alternative. He must make
trade-offs among factors related to health and cost when choosing a
treatment procedure.
To conclude, specific diagnostic categories are reasonably well-
defined but they must be treated as uncertain and multiattributed. A
formal analysis technique must be able to cope with uncertainty and
multiple consequences.
B. DECISION ANALYSIS METHODOLOGY
Decision analysis is a rational, systematic approach to problem
solving. Briefly, decision analysis allows one to [1]:
13

1. outline all alternatives and to consider all possible conse-
quences of each alternative in a systematic way,
2. break a large, complex problem down into a series of smaller,
simpler problems so that different experts or organizational
units can contribute to the solution of the problem in their
particular areas,
3. specify and quantify uncertainty, and determine how critical
the uncertain variables are,
4. specify, in a logical manner, the trade-offs one is willing to
make among outcomes,
5. determine the worth of gathering further information, and
finally
6. determine which decision is the best one to make, and to calcu-
late a measure of how much better that decision is than any
other alternative. This last point is useful in deciding, for
example, whether factors ignored in the formal part of the
analysis could possibly change the decision.
These attributes make decision analysis an attractive method for
coping with the uncertainty and multiple consequences involved in
studying specific diagnostic categories.
The purpose of this section is to acquaint those unfamiliar with
decision analysis with its theory and techniques to the extent neces-
sary to formulate and solve the hypertension problem. The text of
this section is taken from a thesis by Kerns [3] and is included in
the thesis body to serve as a convenient reference for the reader and
to maintain the continuity of the chapter. A more comprehensive treat-
ment of decision analysis is available from Raiffa [4], Giauque [5],
and Keeney [6], to name a few.
Formal decision analysis is a systematic process comprising the
following steps:
1. structuring the problem,
2. assessing relative preferences for possible consequences,
14

3. evaluating the probabilities for uncertainties, and
4. determining the best course of action from the information
in the preceding steps.
This section is organized to explain the methodology of decision
analysis for each step in the formal analysis. Before proceeding, it
is necessary to explain certain terms and notations which are used
throughout the remaining parts of this section.
1. Clarification of Terms and Notations
The terms "is indifferent to," "is preferred to," "lottery"
and "utility function," are widely used in the following section of
this thesis. For clarity, they need to be explained. The term "is
indifferent to" is to be used to mean the same as the statement "the
decision-maker is indifferent to receiving either of the outcomes."
The term "A is preferred to B" is to be used to mean the same as the
statement "the decision-maker prefers A over B."
The term "lottery" is defined as a gamble of some uncertain
event E where the prize X is won if the event E occurs and the prize X^
is won if the event E does not occur. Let p represent the probability
that E occurs and let 1 - p represent the probability that E does not
occur. Notationally, the lottery will be represented as < X
, p , X^ >
.
The term "utility function" is defined as a function u which
assigns a real value to every consequence such that u(a) is larger than
u(b) if and only if consequence a is preferred to consequence b. The
notation u(a) is expressed as the "utility of consequence a."
With the above terms clarified, the steps in a formal decision
analysis process can be explained. The first step in this process is




In structuring a problem in which events are uncertain, the
options or alternatives are enumerated. Next, all the events that can
possibly occur are specified. As a last step, the alternatives and
uncertain events are arranged in chronological order-
A type of diagram known as a dec is ion- flow diagram or "tree"
is a useful tool in decision analysis. It is a chronological arrange-
ment of the alternatives which are controlled by the decision-maker
and the events determined by chance. To illustrate the construction
of a decision- flow diagram, consider the following problem. A decision-
maker is faced with two alternatives, I and II. Both alternatives
involve a situation where the outcomes a or b are uncertain. If a
occurs, then the decision-maker must decide between alternatives III
and IV. Alternative III also involves an uncertain situation leading
to either the outcome c or d.
The decision-flow diagram is shown in Figure 1. Observe that
the branching points or forks are of two types: decision forks and
chance forks. A decision fork is designated by a small square and a
chance fork by a small circle. There is additional information provided
in the diagram which will be discussed in the sections below.
With the alternatives and uncertain events described by a deci-
sion-flow diagram, the next step in the decision analysis process is
the assessment of the relative preferences for the consequences.
3. Establishment of Preferences
The establishment of preferences for the consequences provides
the dec is ion-maker with the basis for the rational choice between the






























































































decision-maker. The consequences may encompass a number of factors
or attributes such as cost, schedule and performance. These attri-
butes might also be of an intangible nature such as goodwill, morale
and politics.
In this step in the decision analysis process, an objective
function is defined to indicate a measure for the preferences for the
consequences
.
A general methodology for defining an objective function in
decision analysis problems exists in the form of utility theory. In
this thesis no attempt is made to develop the theory in detail. It
will be developed only to the extent necessary to formulate and solve
the hypertensive problem.
Consequences may be described by a single attribute or a
multiple set of attributes. Both situations are applicable to the
analysis in this thesis and are separately presented below.
a. Single Attributes
In the case of a single attribute, an objective function,
hereafter called a utility function, can be defined which has the
property that the maximum expected utility among the alternatives
indicates the most preferred action.
A utility function with a single actribute can be construc-
ted in the following manner. Define X and X^ as the upper and lower
limits over a range of possible consequences X. such that X > X. > Xj..
For every possible consequence X., define the utility u(X. ) as the
value p. such that the decision-maker is indifferent to receiving X.
for certain and receiving the lottery < X




ranges from zero to one, where by convention, u(X ) equals one and
u (x*) equals zero.
Once a set of points (X., p.) have been established, a
utility curve may be drawn. Figure 2 illustrates three possible
utility curves. A utility curve generally has two characteristics.
It is smooth and the general shape of the curve is either convex,
straight or concave as illustrated respectively by curves 1, 2 and 3
of Figure 2. Any break in the curve would indicate either an incon-
sistency in the choices for p. in the lottery < X
, p., X . > used to
assess the points of the curve, or a quantum jump in preference for a
small change in X. . A convex curve indicates a risk averse behavior.
That is, the decision-maker is more inclined to take a consequence
known for sure than to take a gamble with the same expected value. A
concave curve indicates that the decision-maker is risk seeking. He
is more inclined to take the gamble than to take the known consequence.
A straight line indicates that the decision-maker acts on the expected
value of the consequence. He is neither risk averse nor risk seeking.
Once the utility curve is established for a single attri-
bute consequence, a value from one to zero is assigned to each conse-
quence corresponding to the point on the curve. A higher value for a
consequence indicates greater preference for that consequence than for
a consequence with a lower utility value,
b. Multiple Attributes
The basic concept of the construction of a utility func-
tion with a single attribute described above can be generalized to the




Utility p. 0.5 —
0.0
Consequence X.
Figure 2. Examples of Utility Curves.
assessment scheme is impractical. First, too many points must be
assessed. Secondly, humans find it difficult to think in terms of
multiple attributes. In decision problems under uncertainty, many
people, when faced with situations where more than one attribute is
relevant, tend to pick the one attribute judged most important to them
and then make the decision on that factor alone.
There are procedures fcr decomposing a multiattributed
utility function into combinations of unidimensional functions.
Keeney [6] shows that a multiattributed utility function can be ex-
pressed in simple additive or multiplicative forms provided the
20

properties of utility independence, pairwise preferential independence,
or pairwise marginality hold. If a utility function of multiple attri-
butes can be expressed in these forms, then the task of defining the
utility function is much easier. Suppose X = (x.. , . . . ,x ) describes a
consequence where u(X) denotes the utility of the consequence X.
Utility independence is defined in the following manner. Let
x.„ = (x-,...,x. , ,x. ..,...,x ). The attribute x. is utility inde-i 1 i-l l+l n x
pendent of x.- if the decision-maker's relative preference for x.,
with x._ held fixed, is the same regardless of the actual value of x._
chosen. Order one mutual utility independence is defined to mean that
x. is utility independent of x.« for all i. If order one mutual
utility independence holds then u(X) can be expressed in the quasi-
additive form
n n n
u(x-,...,x ) = / ^c.u. (x. )+ / j / j c. .u. (x.)u. (x.) + ....1' n' ~ i i v i/
*-J
~ ij i i j 3
Pairwise preferential independence is said to hold if the
trade-offs one is willing to make between attributes taken two at a
time, are not dependent on the values of the remaining attributes.








,xj+1 ,...,xn ), and let x_- be a
particular value from X. ._. The attributes of x., x. are pairwise* ij i j
preferentially independent of X. .„ if one's preference order for the
consequences (x., x., x. .„) with x. .„ held fixed, does not depend onM i' j* ij a.j
the particular value x. ....
If for any pair of attributes x. and x., the lottery
<(x. ,x.),0.5, (x
.
,x .)> is indifferent to the lottery
i j i j
<(x. ,x .),0.5,(x .,x.)> then pairwise marginality is said to hold.
1 J i J
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With the ideas of utility independence and pairwise pre-
ferential independence presented, Keeney's results can be more precise-
ly stated. Let X = (Xj,...,x ) be as previously defined, with n > 3.
If, for some x.x. and x. are pairwise preferentially independent of
(x-p
• • • >xi_i»
x
i+]_» * * * >
x i-i»x -5+1 * * * *»xn ^
for a11
-3 ^ ^ and x i is utility
independent of x.-, then either
u <p X) ki ui (x i : CD
i=l
or
1 + K u(X) = /[ [1 + Kk.u. (x. )I (2)
1=1
where u and u. are utility functions scales from zero to one, the k.
are scaling constants with < k. < 1 and K > -1 is a non-zero scaling
constant. Equation (1) is the additive form and Equation (2) is the
multiplicative form.
Given that the conditions of Keeney's Theorem hold, he pro«
vides a property required to show whether the function is additive (1)
or multiplicative (2). He shows that if pairwise marginality holds
then the function must be additive; otherwise, it is multiplicative.
























Referring co Figure 1, there are three attributes x.. , x_
and Xo which describe each outcome of the tree. For illustration, the







) = uCxj^) + u(x
2
) + u(x„) = u. .
This utility function, in the additive form, maps the consequences x,
,
x« and x_ into a scalar value indicated by u., where i = i,...,8, at
each branch-tip of the tree.
4. Judgmental Probabilities
The decision-flow diagram is one of the decision analysis methods
used in structuring a problem. Utility functions can be used for the
assignment of preferences for the consequences of the outcomes at each
tip of the tree. What remains to complete the information included on
the decision-flow diagram is the assignment of the judgmental probabili-
ties at the chance forks representing the uncertain events. This is
the third step in the decision analysis process.
Raiffa [4] addresses the question of whether the decision-
maker's hunches or value impressions should be calibrated, and if so,
how this should enter into the formal decision analysis process. He
argues that if a decision-maker wishes to act consistently, then he
ought to assign values to judgmental probabilities such that the sum of
the probabilities of an event occurring and not occurring equals one.
This judgmental probability assessment for an event should not depend
on the outcomes. He points out that judgmental probabilities satisfy




Judgmental probabilities are used as a measure of the decision-
maker's beliefs concerning the uncertainty of an event occurring, pro-
vided that these beliefs are consistently applied to every uncertain
event in the analysis. They are assigned to each chance fork of the
tree. In Figure 3, they are represented as p 1 , 1-p, , p~, l-p 9 , p«»
l"Po» Pa> and 1-p, . With this information, the final step in any itera-
tion of the decision analysis process is to determine the recommended
course of action.
5. Recommended Course of Action
Determination of the recommended course of action involves a
sequence of calculations called the "averaging out and folding back"
procedure. This procedure is often referred to as the process of back-
wards induction in the theory of dynamic programming. The procedure
starts at the tips of the tree and consists of computing the expected
utility of each chance fork and the selection of the greatest utility
at each decision fork. The process is repeated for each level of the
tree until the starting decision fork is reached. The alternative with
the greatest expected utility is selected as the recommended course of
action. The selection of the maximum expected utility is an appropriate
means of determining actions consistent with the decision-maker's atti-
tudes and opinions
.
To illustrate the "averaging out and folding back" process, the
information contained in Figure 1 is used. Starting at the chance fork










Moving backwards in the tree, the next fork encountered is a decision
fork, labeled [2J . The value of E., or u^, whichever is greater, is
selected. For illustration, E.. is selected. Continuing backwards
through the tree, a chance fork, labeled [Jj, is encountered. At this








Alternative I has now been reached and the expected utility of this
alternative is E_. In similar fashion, the expected utility of alter-
native II is computed. The results are compared and the alternative
with the greatest expected utility is selected as the recommended course
of action.
C. SUMMARY OF THE CHAPTER
Formal analyses of specific diagnostic categories are seen as a
substantive source for diagnosis-treatment procedures. Specific diag-
nostic categories are uncertain and multiattributed. A formal analysis
technique must be able to cope with uncertainty and multiple outcomes.
Decision analysis has been presented as a formal technique that is
highly effective when applied to uncertain, multiattributed problems.
Decision analysis methodology has been developed, and it provides a




III. THE SPECIFIC DIAGNOSTIC CATEGORY CF
HYPERTENSION: TEST AND TREATMENT DECISIONS
"An estimated 23 million Americans, about one in seven adults,
have hypertension. This makes hypertension the most common chronic
disease in the United States. Half of the people with hypertension
don't know they have it. Half of the people who know they have it are
not being treated for it. And half of those treated for it are not
being treated adequately" [7], Optimal procedures for diagnosing and
treating hypertension would be desirable.
The specific diagnostic category of hypertension is reasonably
well-defined in the sense that treatment alternatives and the measures
of patient welfare are known. However, no two hypertensives are
exactly alike and this complicates the problem. Each hypertensive
patient has a unique health profile. This unique profile complicates
the formal analysis of hypertension as the uncertainty that occurs
in various treatment alternatives is a function of this profile.
Theoretically, each hypertensive profile has to be analyzed separately.
Clearly, this is not practicable.
The purpose of this chapter is to develop a medical background for
hypertension sufficient to state and solve a well-defined hypertensive
problem. Accordingly, Section A defines basic hypertension terminology
and presents three classifications of hypertension. From these three
classifications, sustained diastolic, hypertension is selected for
further analysis. Section B investigates sustained diastolic hyperten-
sion—concentrating on drug regimens typically used to control blood
26

pressure, surgically correctable causes of sustained diastolic hyper-
tension, and laboratory tests that can detect these surgically correct-
able causes. Finally, Section C confronts the problem of unique hyper-
tensive patient profiles and states the sustained diastolic hypertension
problem in a well-defined form.
A. MEDICAL BACKGROUND
There are two components of blood pressure - "systolic" and
"diastolic." Systolic pressure occurs when the heart contracts and
is the higher of the two pressures. Diastolic pressure occurs during
dilation or expansion of the heat [8] . Readings of blood pressure
are typically made of both figures. For example, a typical blood
pressure report is 120/80 mm Hg where 120 is the systolic pressure
and 80 is the diastolic pressure.
There are two classifications for the disease of hypertension -
"secondary" and "essential." Secondary hypertension is the result of
a known cause while essential hypertension represents hypertension for
which there is no known cause. Essential hypertension comprises about
90 percent of the hypertensive population [9].
When a resting supine adult has an arterial pressure of 160/90
mm Hg or higher, hypertension is considered to be present. However,
hypertension can be further subclassified into three groups, including:
labile, systolic, and diastolic. Labile hypertension occurs when a
patient's blood pressure checks high on one visit but then returns to
normal on subsequent visits. Patients with intermittently high and
normal blood pressure should be reexamined at regular intervals as




Sustained systolic hypertension exists when the systolic blood
pressure is abnormally high (usually greater than 160 mm Hg), but the
diastolic blood pressure is normal (usually less than 90 mm Hg).
Sustained systolic hypertension often suggests particular causes, such
as aortic insufficiency and arteriosclerosis [9]. Prognosis, and
therefore treatment, of systolic hypertension lacks consensus among
health physicians. Harrison [9] says, "the treatment of isolated
systolic hypertension is not recommended." However, Koch-Weser [10]
states "it is no longer reasonable to accept that systolic hypertension
can and must be therapeutically ignored." The results of well-con-
trolled prospective studies geared to measuring the prognosis of this
case are needed.
Sustained diastolic hypertension is defined as diastolic blood
pressure greater than 90 mm Hg. One type of sustained diastolic hyper-
tension is malignant hypertension. The patient with malignant hyper-
tension often has blood pressure above 200/140 mm Hg. But it is the
papilledema (abnormal accumulation of fluid in the eyes), not the level
of blood pressure, that specifically defines malignant hypertension.
Malignant hypertension has serious health consequences. As a result,
diagnosis-treatment procedures for this disorder are relatively
standard, including extensive laboratory work-ups and immediate treat-
ment [9]
.
Sustained diastolic hypertension that is not malignant (hereafter
referred to as sustained diastolic hypertension) is selected as the
focus for a decision analysis because:




2. there is consensus among doctors that uncontrolled sustained
diastolic hypertension can cause vascular disease, organ
damage, and premature death; and
3. determinations of when to use certain laboratory tests that
can detect surgically correctable causes of sustained diastolic
hypertension have not been established.
B. SUSTAINED DIASTOLIC HYPERTENSION
A convenient way to discuss sustained diastolic hypertension is to
subdivide it into smaller categories. First, sustained diastolic hyper-
tension is divided into essential diastolic hypertension and secondary
diastolic hypertension. Next, secondary diastolic hypertension is
broken down into cases having surgically correctable causes and into
cases having nonsurgical!/ correctable causes. This classification
scheme is presented in Figure 3 [11].
The physician who treats sustained diastolic hypertension must, in
effect, treat the various categories presented in Figure 3. All of
these categories can normally be effectively treated with drugs.
Hypertensive drug therapy currently being used is relatively standard.
Conn [12] recommends the drug program given in Table II
»
TABLE II. Drug Treatment for Hypertension
Diastolic Blood





90 < dbp < 110










New drugs are beginning to emerge (e.g., Inderal), but today most


































5. Coarctation of the
aorta
Figure 3. Sustained Diastolic Hypertension Categories
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Each of these drugs can have unpleasant side-effects. Oral diure-
tics usually have negligible side-effects but can cause mild drowsi-
ness. Methyldopa can produce drowsiness, dry mouth, mood disturbances,
and fever. And hydralazine can cause headaches, arthritis, and fever
[12]. However, most people experience very few of these side-effects,
and the physician can generally find some combination of these drugs
that will successfully control hypertension and cause very minor side-
effects [13].
A category of sustained diastolic hypertension where the physician
has several diagnosis-treatment options is surgically correctable
diastolic hypertension. The ideal treatment for this category, assum-
ing the patient is an acceptable surgical risk, is surgery. However,
laboratory tests are generally required to expose surgically correct-
able causes. To develop an adequate understanding for this hyperten-
sive category, surgically correctable causes of sustained diastolic
hypertension are discussed.
Pheochromocytoma is a relatively rare phenomenon caused by tumors
that are developed by cells from the adrenal glands. Ninety-five per-
cent of these tumors are located in the abdomen [9] . About .5 percent
of the hypertensive population (all patients with sustained diastolic
hypertension) are believed to have these tumors [14]. Surgery
generally consists of a careful abdominal examination through a
generous traverse upper abdominal examination. Surgery results in a
complete remission of symptoms unless multiple tumors exist [9]
.
Primary aldosteronism sometimes referred to as Conn's Syndrome,
usually results from a benign tumor of the adrenal gland. Treatment
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is surgery exploring both adrenal glands. After successful removal of
aldosterone producing tumors, 70 percent of the patients became norma-
tensive, 25 percent have a significant lowering of their blood pressure,
and five percent have no change [9] . This condition is believed to be
surgically correctable in about one percent of the hypertensive popula-
tion [14],
Cushing's Syndrome is a rare disorder that is often a result of
adrenal tumors. These tumors exist in about .4 percent of the hyper-
tensive population [14]. Cushing's Syndrome can also be caused by
other abdominal tumors and pituitary malfunctions . Surgery is the only
completely satisfactory treatment for adrenal tumors [9]. Successful
surgical corrections for other abdominal tumors and pituitary malfunc-
tions have been rare [11].
Renal hypertension is the most common type of potentially curable
hypertension. The two subdivisions of renal hypertension are renal
arterial hypertension and renal parenchymal hypertension [15]. Surgi-
cally correctable forms of these two internal disorders occur in
about 4 percent of the hypertensive population [14]. Renal arterial
hypertension occurs when a major renal artery becomes constricted,
decreasing blood flow to that kidney. Treatment consists of surgery
where the constricted portion of the artery is removed. Parenchymal
hypertension occurs when the smaller blood vessels in the kidney cease
to function properly. Surgical correction for this disease usually
requires complete removal of a kidney and, hence, can only be done,
when the disease is unilateral. Surgical treatment fcr renal arterial
constriction and for unilateral parenchymal disease usually results in
a normotensive patient [9].
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Coarctation of the aorta results from a physical abnormality in
the aorta causing a decrease in blood flow to the lower portion of the
body [15] . Coarctation of the aorta is responsible for about one per-
cent of the hypertensive population [14] • Surgery is the ideal cure
in these cases [9].
Surgery for the above internal disorders requires the patient
spend about eight days as an inpatient, followed by three weeks of
sedentary activity [16], This, of course, assumes no surgical compli-
cations.
Having developed an understanding for surgically correctable
causes of sustained diastolic hypertension, the question now becomes,
"How can one detect these causes?" Harrison [9] recommends a basic
set of laboratory tests as a first step when it is desired to investi-
gate for surgically correctable causes of sustained diastolic hyperten-
sion. This particular set of tests is suggested because collectively
the tests investigate all surgically correctable causes, and all tests
can be administered in one day as an outpatient. The individual tests,
and the surgically correctable causes they investigate are given in
Table III. Test effectiveness is given for primary test indicators.
If a hypertensive patient has basic test indications that suggest
a surgically correctable disorder, auxiliary tests are normally con-
ducted. These auxiliary tests are specifically designed for the five
surgically correctable disorders and are performed on an inpatient
basis. They require about two days in the hospital. A positive
auxiliary test is virtually always followed by surgery [16],
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TABLE III. Basic Laboratory Tests
A. Urine
1. urinalysis: renal
2. urine culture: renal
3. 24 hr. catacholamines : presence indicates 90$ chance oj
pheochromocytoma
B. Serum
1. Na, K, CI, C0_: low K indicates 50$ chance of primary
aldosteronism
2. Creatinine: renal




1. ECG: general health
2. X-RAY: coarctation of aorta
general health






C. TEST AND TREATMENT DECISIONS
A physician's first contact with a patient is usually through a
clinical evaluation where a patient's history is reviewed and a
physical exam is conducted. If this clinical evaluation detects the
disease of hypertension, the doctor must decide on subsequent diagnosis*
treatment procedures. Table IV [8,9,11] develops the general organiza-
tion of a clinical evaluation. Specific data are given when they have
application for formulating and solving the hypertension problem.
The clinical evaluation is able to substantiate the presence of
sustained diastolic hypertension. If sustained diastolic hypertension
is due to nonsurgically correctable causes, these causes are normally
apparent in the physical exam and can be treated directly. Occasion-
ally, symptoms indicating surgically correctable causes are apparent
in the clinical evaluation. If these symptoms are present and the
patient is a suitable candidate for surgery, the logical course of
action is to administer laboratory tests that can confirm or deny
surgically correctable disorders. The fundamental problem confronting
the physician is choosing diagnosis -treatment procedures for patients
with sustained diastolic hypertension who have no apparent secondary
symptoms
.
Based on the medical discussion in Section B, there are three
options available to the doctor for treating sustained diastolic
hypertensive cases with no apparent secondary symptoms - do nothing,
investigate for possible surgically correctable causes, or treat
hypertension with drugs. This is a problem well-suited for a decision
analysis except for the fact that each hypertensive patient has a
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TABLE IV. Clinical Evaluation
A. Types of Hypertension
1. normotensive: blood pressure < 90/160 mm Hg
2. labile: intermittently high blood pressure
3. sustained systolic: systolic blood pressure > 160 mm Hg
4. sustained diastolic: diastolic blood pressure > 90 mm Hg





C. General State of Health
1. evidence of vascular disease
2. heart murmurs
3. papilledema




2. patient history - development of hypertension < 35 or > 50
favors surgically correctable hypertension
E. Symptoms and Exam Pattern Pertaining to Sustained Diastolic
Hypertension








a. highest incidence in young adults
b. 50$ have intermittent hypertension with sudden attacks of
severe headache
3. primary aldosteronism
a. highest incidence in young adults
b. occurs in twice as many females as males
4. Cushing's Syndrome
a. classic symptoms of weight gain and mooning of face
observed in about 95$ of patients
5. renal vascular disease
a. highest incidence in older adults
b. clinical evaluation is of little diagnostic value
6. coarctation of the aorta
a. weak femural pulse observed in 95$ of patients
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unique health profile. Blood pressure is a continuum - everyone has
blood pressure, but rarely do people have exactly the same blood
pressure. And since hypertension is abnormally high blood pressure,
rarely do hypertensive patients have the same level of hypertension.
Furthermore, hypertension occurs in patients who have different ages
and degrees of general health making a given level of hypertension
more serious in one person than in another. This results in a differ-
ent health prognosis for each hypertensive patient.
To understand the impact of unique health patient profiles on a
decision analysis, the mechanics of decision analysis presented in
Chapter II are reviewed. Recall that a part of the decision analysis
formulation consists of determining the possible outcomes or conse-
quences for selected alternatives and obtaining the probability that
these consequences will occur. When each hypertensive patient has a
unique health profile, the probability that a given consequence will
occur is different for each patient. As a result, each hypertensive
patient theoretically requires an independent analysis.
To make this problem tractable, this infinite number of possible
health profiles must be divided into a finite number of discrete health
profiles. To develop discrete health profiles, one must identify what
factors in a patient's health profile affect the probability that
possible consequences will occur. Once these factors are identified,
they can be put into discrete forms that will provide the basis for
discrete health profiles.
Identifying factors that affect the probability that consequences
will occur requires that one be aware of these consequences. The
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detailed development of alternatives and their consequences is done in
Chapter IV where the problem is formulated. However, the problem as
it now stands is relatively well-defined and these consequences can be
discussed in general terms. In the case of hypertension, the conse-
quences are measures of patient welfare that must be simultaneously
considered with each alternative. These consequences can be logically
divided into factors related to health and factors related to cost.
Factors related to cost include such things as the cost of tests,
surgery, and drugs; factors related to health include such things as
surgical complications, and organ damage and premature death if blood
pressure is not controlled.
The logical source for factors that affect the probability of
occurrence of cost and health consequences is the clinical evaluation.
The clinical evaluation probes most aspects of hypertensive patient
profiles, and the content of this evaluation is available to the
decision-maker a priori. Inspection of Table III gives five factors
that affect the probable occurrence of cost and health consequences.
These factors are surgically correctable symptoms, sex, age, level of
diastolic hypertension, and the general state of health of the patient,
Patients with surgically correctable secondary symptoms have a higher
probability of obtaining a surgical cure for their hypertension.
Women tolerate high blood pressure better than men and, as a result,
have less chance of health complications when high blood pressure is
not controlled. The age of the hypertensive patient directly affects
the probable occurrence of health and cost outcomes. A young patient
with uncontrolled high blood pressure is more likely to experience
severe health complications than an older patient with the same level
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of blood pressure. And a young patient being treated for hypertension
by drugs will probably incur more expense for medication during the
course of a normal life than an older patient. The level of diastolic
pressure clearly affects the prognosis of the untreated patient. A
patient at a certain age with a high level of diastolic blood pressure
will probably experience more severe organ damage and a greater reduc-
tion in longevity than a man at the same age with a lower diastolic
blood pressure. The general state of health of a patient affects the
probability that surgical complications will occur if surgery is
performed.
Having identified five factors that affect the probabilities of
cost and health consequences, the next step is to divide these five
factors into discrete ranges. The general state of health of a patient
is very difficult to divide into discrete levels since there are so
many variables involved in a person's general health. As a result,
this paper simply considers hypertensive patients to be either a low
surgical risk or not a low surgical risk. Surgically correctable
symptoms are also difficult to divide into discrete ranges, since the
scope of possible symptoms is infinite. This paper treats surgically
correctable symptoms as either existing or not existing. Age is
divided into three groups - less than 35, 35 to 50, and older than 50
years of age. These categories are chosen because hypertensive patients
less than 35 and greater than 50 are more likely to have surgically
correctable hypertension.
Sustained diastolic hypertension represents all blood pressures
greater than 90 mm Hg. This paper assumes diastolic blood pressures
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greater than 120 mm Hg fall into the malignant category as these cases
require immediate treatment, and the seriousness of the disease justi-
fies elaborate laboratory work-ups. As a result, patients with
diastolic blood pressures over 120 mm Hg are excluded from the problem.
The term "sustained diastolic hypertension" now refers to diastolic
blood pressure between 90 and 120 mm Hg. This range of blood pressure
is divided into two smaller groups, 90 to 105 mm Hg and 105 to 120
mm Hg.
There are 48 possible combinations of the preceding subdivisions
of the five factors that affect the probable occurrence of health and
cost outcomes. These 48 combinations represent 48 discrete hyperten-
sive profiles. Not all of these profiles are appropriate for a
dec is ion analysis. Patients with surgically correctable symptoms have
already been excluded from the scope of the problem as it is assumed
that the logical alternative for these patients is to perform labora-
tory tests. And patients observed to be other than a low surgical
risk are excluded from the analysis as their treatment depends on the
general state of health of the patient. This results in six male and
six female hypertensive profiles suitable for a decision analysis.
These profiles are three age groups each of which has two blood pres-
sure groups for low surgical risk patients with no secondary symptoms.
The resulting problem to be solved is illustrated in Figure 4.
D. SUMMARY OF THE CHAPTER
Sustained diastolic hypertension has been selected for a decision
analysis application. A decision analysis of sustained diastolic
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patient profiles. As a result, this chapter has developed 12 discrete
hypertensive profiles suitable for a decision analysis.
The problem to be formulated in Chapter IV can be briefly stated
as follows:
If a patient has sustained diastolic hypertension, is a low
surgical risk, and has no secondary symptoms, the physician has
three options. These options are to do nothing, to investigate
for surgically correctable causes for the hypertension, or to
treat the hypertension with drugs. These three options are analyzed
for men and for women in each of six age/blood pressure groups.

IV. PROBLEM FORMULATION
Decision analysis methodology developed in Chapter II gives three
steps required for problem formulation. These steps are:
1. to structure the problem,
2. to establish preferences for outcomes, and
3. to obtain judgmental probabilities.
Structuring the problem is done in three steps. First, all problem
alternatives are enumerated. These problem alternatives are based on
the medical discussion of hypertension given in Chapter III. Secondly,
all uncertain events for these alternatives are noted. The final step
is to assemble the alternatives and their events in a chronological
order. The ultimate objective in structuring the problem is to develop
the alternatives and events in a decision tree.
Establishing preferences is done in two steps. All possible conse-
quences of the decision alternatives are obtained. Then multidimen-
sional utility theory is applied to these multiple consequences to
reduce them to a single level of effectiveness.
The final step of problem formulation is to assess judgmental
probabilities for all uncertain events. These probabilities are ob-
tained from medical statistics given in Chapter III and from informal
physician interviews.
A. STRUCTURING THE FROBLEM
The first step in structuring a problem is to identify all alterna-
tives available to the decision-maker. A logical starting point for
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identifying treatment alternatives is to examine the three treatment
options developed in Chapter III. Based on the discussion of test and
treatment procedures given in Chapter III, each of these three treat-
ment options implies an initial alternative. The treatment options
and their corresponding initial alternatives are given in Table V.













Do Nothing Do Nothing
If basic tests are performed, there are two additional alternatives
available to the doctor - perform auxiliary tests and conduct surgery.
As a result, for the three treatment options, there are five possible
alternatives: perform basic tests, perform auxiliary tests, conduct
surgery, administer drugs, and do nothing.
Now that treatment alternatives are identified, the next step in
structuring the problem is to obtain the uncertain events that can
occur as a result of these alternatives. The uncertain events for each
of the five preceding alternatives are developed in two steps. First,
general events to the specific alternatives are given. These general
events are a basic description of logical possible outcomes of the
alternatives. Then if the general events are not sufficiently specific
for a decision analysis, they are analyzed within the medical context
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of the alternative they represent and restated in more specific terms.
During this process, an attempt is made to represent all specific
events as concisely as possible, thereby keeping the problem structure
simple. Alternatives, general events, and specific events are given
in Table VI.
Most general events are sufficiently specific to be used in the
actual analysis. The general event of an equivocal result from a
basic set of tests or from auxiliary tests is eliminated as it is
assumed that the doctor can resolve these cases to either positive or
negative results.
Two general events that must be put into more specific terms are
surgical complications and drug complications. These two general
events are alike in that they each imply many possible specific events.
Drug complications can be anything from mild drowsiness to chronic
depression to violent reactions. And surgical complications include
prolonged convalescence, morbidity, and mortality. This paper assumes
that a patient with sustained diastolic hypertension will not continue
taking a drug that causes side-effects worse than mild drowsiness.
Furthermore, 30 days is viewed as enough time to try all possible drugs
in an attempt to overcome undesirable side-effects. As a result, un-
acceptable side-effects are viewed as drug side-effects worse than
mild drowsiness that cannot be corrected in 30 days. Surgical compli-
cations for low surgical risk patients undergoing routine abdominal
surgery are rare. Most patients experience a standard convalescence.
Occasionally a patient dies during surgery. However, a patient very
rarely incurs a permanent or prolonged disability. Therefore, the only
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TABLE VI. Alternatives, General Events, Specific Events












Blood pressure control (or)






Blood pressure control (or)
no blood pressure control
Surgical complications (or)
no surgical complications













(or) no blood pressure
control






specific surgical complication considered in the problem structure is
death.
The ultimate goal of this section is to represent the structure of
the problem in a decision tree. To do this, the chronological ordering
of the five alternatives must be established. The initial alternative
for each of the decision options was given in Table V. But the chronol-
ogy of subsequent alternatives is not definite. Theoretically, any of
the remaining four alternatives can follow the initial alternative for
each option. However, not all of these alternative chronologies are
logical. The chronology for the option of doing nothing can be dis-
posed of quickly as this option has but one alternative and is obviously
an end in itself. The chronology for the other two options is based on
the following assumptions:
1. If basic tests are conducted and the tests are positive, it is
assumed that auxiliary tests are performed.
2. If auxiliary tests are positive, it is assumed that surgery is
performed.
3. If the basic tests are negative, if the auxiliary tests are
negative, or if the surgery fails to control the high blood pressure,
and if drugs have not been previously administered, it is assumed that
drugs are administered in an attempt to treat the hypertension.
4. If the basic tests are negative, if the auxiliary tests are
negative, or if surgery fails to control the high blood pressure, and
if drugs have been previously tried and found to be unsatisfactory, it
is assumed that there is no blood pressure control.
5. If drugs are administered and the drugs either have unaccept-
able side-effects or do not control the high blood pressure, and if
basic tests have not been previously conducted, it is assumed that
basic tests are performed.
6. If drugs are administered and the drugs either have unaccept-
able sida-effects or do not control the high blood pressure, and if
basic tests have been previously performed, it is assumed that there
is no blood pressure control.
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7. If drugs control the high blood pressure, and the drugs have
acceptable side-effects, but the patient discontinues the drugs, it
is assumed there is no blood pressure control.
8. If drugs control the high blood pressure and the drugs have
acceptable side- effects, and the patient continues the drugs, it is
assumed that there is blood pressure control.
Blood pressure control and no blood pressure control as used in the
above assumptions denote a condition that exists throughout the
remaining life of the patient.
If the five alternatives are ordered for the three treatment
options using the preceding ordering assumptions, the treatment options
terminate in one of the following three events: blood pressure con-
trol, no blood pressure control, or death. The two events of blood
pressure control and no blood pressure control are not suitable for
terminating alternative orderings as they imply subsequent outcomes.
The possible outcomes of these two events must be understood before
the problem can be analyzed.
A logical way to terminate the outcomes of blood pressure control
and no blood pressure control is to decide whether they cause health
complications or they don't cause health complications. This paper
assumes there are no health complications if there is blood pressure
control, and there are health complications if there is no blood
pressure control. As a result, the three events of death, health
complications and no health complications provide a well-defined
termination for all possible alternative orderings.
The general event of health complications must be put into specific
terms. Health complications are like drug and surgical complications
in the sense that these general events imply many possible specific
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events. Untreated hypertensives can experience irreparable damage to
the eyes, heart, and kidneys. However, the most significant prognosis
of uncontrolled high blood pressure is premature death. As a result,
this paper uses reduction in normal life as the sole specific event for
health complications. Table VII [17] gives life expectancies for the
12 health profiles.
TABLE VII. Life Expectancies
Diastolic Blood
Pressure mm Hg
Life Exp actancy (years
)
Age (years) Male Female
< 90 77 82
< 35 90 - 105 60 67
105 - 120 (48) (55)
< 90 77 82
35-50 90 - 105 68 75
105 - 120 (56) (63)
< 90 77 82
>50 90 - 105 73 79
105 - 120 (65) (70)
( ) are extrapolated values.
Based on the preceding discussion, the alternatives and events for
the three treatment options are now chronologically arranged in a
decision tree given in Figures 5, 6, and 7. The specific events of no
blood pressure control and unacceptable side-effects for the drug
alternative have been combined into "other" as the distal portions of the
tree for these two events are the same. Note that although there are
five alternatives, the problem structure has only three strategies, one
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Before discussing how multidimensional utility theory can be used
to formulate outcome preferences, it is best to dispense with some
preliminaries. First, two terms that occur throughout this section are
"analyst" and "decision-maker." The analyst is the party who identi-
fies treatment alternatives and the possible outcomes of these alterna-
tives. Having identified possible outcomes, the analyst then obtains
a relative measure for these outcomes by assessing decision-makers,
where decision-makers are parties who have an interest in possible
outcomes. The author performs the functions of the analyst in this
paper. Theoretically, there are three categories of dec is ion-makers:
the patient, the doctor, and the public sector. However, to limit the
analysis, this paper analyzes hypertension using only the patient as
the decision-maker. Secondly, a military installation is selected for
the environment of the hypertensive analysis. This environment is
chosen because local military doctors are interested in optimal hyper-
tensive diagnosis-ti'eatment procedures for military personnel. In
this military installation, the government finances all medical
services. As a result, the patient incurs no medical charges.
Giauque [18], in his work on upper respiratory infection, success-
fully used multidimensional utility theory to obtain single measures
of effectiveness for decision outcomes. The technique developed in
his work is applicable to the problem of hypertension and, therefore,
is used in this paper. Accordingly, this section is a recapitulation
of Giauque' s technique, and is presented only to the extent necessary
to solve the hypertension problem. It is specifically designed for
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the case where the patient is the decision-maker and the government is
the sole provider.
The first step in obtaining outcome preferences is to develop a
result vector. A result vector is composed of several dimensions.
Each dimension is composed of components. Together, these components
represent all possible consequences of the problem. The unique quality
of a dimension is that it has one, and only one, of its components in
each tree branch. A straight-forward method of obtaining dimensions
and their components is to examine branches of the decision tree given
in Figures 5, 6, and 7, noting all possible dimensions and components.
This examination reveals five dimensions and 12 components. These
dimensions and their components complete the result vector, and are
given in Table VIII.
Dimension components normally have consequences concerning both
cost and health. The health and cost consequence for each component
is given in Table VIII. Health factors are based on the medical dis-
cussion of hypertension given in Chapter III and Section A of this
chapter. Costs are primarily based on Army Regulation No. 40-330 [19j,
which gives rates for Army medical department activities. When cost
data are not available in this regulation, medical costs from the
private sector are used.
Now that the result vector has been developed, multidimensional
utility theory is applied to the result vector. The goal of this








Dimens ion Health Cost ($)
Basic Basic tests (1) day-outpatient 140
tests
No basic tests Perfect health
Auxiliary Auxiliary tests (2) day- inpatient 260
tests
No auxiliary tests Perfect health







No drugs Perfect health
Low reduction
in longevity Table VII
Longevity
High reduction
in longevity Table VII






No surgery Perfect health
Cost figure for patient taking pills for 35 years
Pairwise marginality holds between health and cost consequences.
This can be represented as
u(x) = Kj uh (xh ) + (1 - Kj) uc (x.) (3)
where u(x) is a single measure of effectiveness of the result vector,
and x, and x refer to health and dollar consequences.
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Pairwise marginal ity also holds among costs to the patient, the
doctor, and the public sector. This can be expressed as
u (x ) = K u (x ) + K u (X ) + Kufic) (4)c^c PPP ddd ggg
where x , x, , and x represent costs to the patient, the doctor, and
the government. Since the government is paying for all medical
services, x and x, are zero. This results in
P d
u (x ) - K u (x ) (5)
c -c ggg
where K expresses the patient's concern for governmental medical
O
costs. This paper assumes K is zero. As a result,
u (x ) = , and (6)
c —
c
«<*> - un (^h } • (7)
Stated in words, when the patient is the decision-maker and the
government is financing the medical services, health consequences are
the only relevant components of the result vector.
To obtain the utility structure for the health vector, the analyst
must examine each dimension of the health vector taking all combina-
tions of dimensions two at a time, to determine which, if any, of the
characteristics of first order utility independence, pairwise preferen-
tial independence, and pairwise marginality hold for each combination.
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Pairwise marginality between two dimensions implies indifference
between such gambles as
^





22 )j (x12 X21 ) / *
where x _ and x. „ are consequences of one dimension and x - and x
are consequences of a second dimension. Pairwise marginality was
found to hold between all possible combinations of the following four
dimensions: basic tests, auxiliary tests, drugs, and longevity. The
tests used to justify pairwise marginality between all combinations of
these dimensions are not reproduced in this paper. However, an
example is done to illustrate the method. Choose the dimensions of
auxiliary tests and drugs. The author considers the gamble of
/ (auxiliary tests, pills), (no tests, no pills) y
sufficiently close to being equivalent to the gamble of
/(auxiliary tests, no pills), (no tests, pills) / .
Pairwise marginality was decided not to hold between the dimension
of surgery and all other dimensions. For example, clearly the gamble
of
^ (death, no pills), (no surgery, pills )}
The notation < A,B > denotes a gamble with a 50$ chance of A or B,
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is less preferred than the gamble
^ (death, pills), (no surgery, no pills) / .
However, pairwise preferential independence and utility independence
seemed appropriate between the dimension of surgery and all other
dimensions. Again, not all combinations are tested here but an
example is given to demonstrate the technique. Compare the relation-
ship of the drug dimension to the surgery dimension. Would the price
one would be willing to pay, in terms of drug side-effects and the
inconvenience associated with taking drugs, to avoid routine abdominal
surgery, depend on the particular levels of other consequences? Also,
do one's feeling about the relative unattractiveness of routine
abdominal surgery depend in any way on the amount of drug side-effects?
If the answers to these and similar questions is "no," or even "almost
no," the assertion of utility independence and pairwise preferential
independence is justified or "almost justified" for this particular
combination of dimensions. The answers to these questions and similar
questions are matters of opinions, but it seemed reasonable to assume
the answers justified the independence properties stated above.
To summarize, the health utility interrelationships as viewed by
the author are:
1. pairwise marginality holds between all combinations of the four
dimensions of basic tests, auxiliary tests, drugs, and
longevity, and
2. pairwise preferential independence and utility independence
holds between the dimension of surgery and each of the above




With the health utility interrelationships established, the utility
function over all five dimensions is now developed.
The additive formula can be used for the four dimensions having
the common characteristic of pairwise marginality. The multiplicative
formula can be used between the dimension of surgery and the other
four dimensions. This results in







where x, represents dimensions having pairwise marginality, x_ is the





) + u (x
2
) . (9)
Since pairwise marginality holds among the dimensions of x-
,
ui^i> - Z Ku uu <*h> • <10 >
i=l
In order to determine the utility function over the entire health con-
sequence space, it is necessary to assess the five unidimensional
utility functions and the seven constants that occur in Equations (8)
and (10). These data requirements are summarized in Table IX.
To obtain the 12 unknowns in Table IX, two assessments are con-
ducted. First, the analyst assesses all health consequences. Next,
patients are assessed on a selected number of health consequences.
When these two assessments are complete, they are combined to obtain a
reasonably accurate assessment of the patients' attitudes over all
health consequences. This procedure permits brief patient interviews
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TABLE IX. Data Requirements to Determine Utility Functions
A. Unidimensional Utility Assessments Required
1. basic tests: u.-Cx..)












B. Constants to be Determined by Assessment
1. K, K. , K? , L., Kio» Ki-i» Ki& : constants occurring in
the equation decomposing the utility over health dimensions
and allows the patient to focus on a few key issues, thereby improving
the quality of the assessment.
Table VIII gives all consequences of the health vector. There are
13 possible consequences. However, since one consequence in each
dimension is equivalent to perfect health, this leaves eight distinct
possibilities plus the "perfect health" possibility for a total of
nine. The nine possible health consequences are given in Table X, and
are ordered from most desirable to least desirable.
The gambles assessed by the analyst are also given in Table X. The
gambles are constructed so it is easy for the assessor to think about
the gambles. Once the p.'s are assessed, they are adjusted to a high
reference of perfect health and a low reference of death. These
adjusted probabilities represent the analyst's utility for the health
consequence, and are hereafter referred to as UA ( . ).
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tests AT PH P l
AT
Auxiliary
tests Dl PH ?2
Dl
Unacceptable
side effects SI PH P3
SI
Normal
surgery D2 PH p4
D2 Pills Rl PH P5
Rl
Low reduction
in longevity R2 PH p 6
R2
High reduction
in longevity S2 PH p7
S2 Death .01
p. is assessed such that the health consequence is equivalent to
a p. chance of the high reference and a (1 - p.) chance of the
low reference.
The health consequences of auxiliary tests, routine surgery and
pills are selected for patient assessments as these consequences have
a range of utilities that provide a good representation of the complete
health vector. The assessment procedure consists of first having the
patient order from most desirable to least desirable the three selected
consequences. Next, the analyst assesses gambles over the three con-
sequences of auxiliary tests, routine surgery, and pills in the vector
**
If this ordering is inconsistent with the analyst's ordering given




space bounded by the consequences of perfect health and low longevity,
Table XI gives the health consequences used for patient assessments
and the gambles used to obtain patient preferences. Note that only
three quantities are assessed from the patient: AUl, AU2 and AU3.






























AU. is assessed such that the health consequence is equivalent
to an AU. chance of the high reference and a (1 - AU.) chance
of the low reference.
Once the analyst's assessments and the patients' assessments are
complete, the patient assessments over all health consequences are
obtained using the interpolation formulas given in Table XII, where
U ( . ) designates utility obtained from interpolation formulas.
62

TABLE XII. Utility Interpolation Formulas
A. For consequences PH, S2, and R2, assume the same utilities





D2: U(D2) = AU3 x U(FH) + (1 - AU3) x U(R2)




C. For intervening consequences, Dl for example:
U(D1) = F x U(AT) x U(S1) where
F = [UA(D1) - UA(S1)]/[UA(AT) - UA(Sl)]
Sufficient data are now available to calculate the five unidimen-
sional health utility functions given in Table IX „ Table XIII derives
the five functions.
In order to evaluate the seven constants appearing in the health
utility function, the U ( . ) ranking is considered as a multidimen-
sional utility ranking over particular points of the utility space.
In particular, consider one of the consequences listed in Table XIV,
for instance, consequence D2. In the preceding development, conse-
quence D2 was defined as pills taken two to four times per day for the
rest of the patient's life, but implicit in this definition was the
idea that everything else was right with the patient. Thus, consider-
ing D2 as a point on the multidimensional health space, D2 is more
fully described as a point where no basic tests are given, no auxiliary
tests are given, no surgery is conducted, the patient lives a normal
life, and pills are taken two to four times per day for the rest of
the patient's life. Referring then to Table XIII, it can be seen that
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TABLE XIII. Derivation of Unidimensional Health Utility Functions






1. no basic tests (PH) : u.j-CPH) = 1




B. Auxiliary tests: u..„(x.._)
Two possibilities
1. no auxiliary tests (PH) : u (PH) = 1











(Dl) = [U(D1)-U(D2)]/[1 - U(D2)]









longevity (Rl): u^Rl) = [U(Rl)-U(R2)]/[l - U(R2)]








i. no surgery (PH) : u (PH) = 1
2. normal surgery (SI): u (Si) = [U(S1)-U(S2)]/[1 - U(S2)]





at point D2, again considered as a point in multidimensional health
space, the utility function u-^., has a value of zero, while u_ 19 ,
uioo» ui/o anc* uoo have values of one. Other entries in Table XIV are
derived in a similar manner.











PK 1 1 1 1 1
T 1 1 1 1
AT 1 1 1 1
D2 1 1 1 1
R2 1 1 1 1
S2 1 1 1 1
Recall now the equation for health utilities




If the values of Table XIV are substituted into (8
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U(AT) = K
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substituting Equation (17) into Equation (12) yields
^ = U(S2) - .01 (18)







) = 1 (19)
As a result, Equations (13), (14), (15) and (16) can be expressed as




Subtracting Equations (20), (21), (22), and (23) from Equation (17)
yields
Ku = 1 - U(T) (24)
K
12
= 1 - U(AT) (25)
K^ = 1 - U(D2) (26)
K^ = 1 - U(R2) (27)
Equation (19) can be solved for K_, resulting in
K
2
= [1 - K
x









U(AT) = (Kn + K13 + K14 )
U(T) = ( K12 + K13 + K14 )









13 )]| /K1 [U(R2)-(K11+K12+K13 )] (29)
Having obtained K, Equation (28) can now be used to obtain K„.
C. ASSESSMENT OF JUDGMENTAL PROBABILITIES
Probabilities for the uncertain events that occur in the decision
tree given in Figures 5, 6 and 7 were obtained by informal interviews
with physicians [13, 16] and from medical statistics given in
Chapter III.
Table XV is a convenient way to present event probabilities. Using
these probabilities, all decision tree probabilities can be determined
For example, if "B" is known, then the probability that auxiliary tests
are negative is equal to one minus "B". It is assumed that the proba-
bilities in Table XV do not depend on preceding events unless it is
specifically indicated. For example, the probability that the basic
tests are positive is valid only if the patient has no secondary
symptoms. However, the probability that drugs control high blood
pressure and have no unacceptable side-effects is assumed to be con-
stant for all combinations of preceding events.
The probabilities described in Table XV are given in Table XVI
for the 12 health profiles and the five surgically correctable causes
of sustained diastolic hypertension. The probability of death is
assumed to be two percent in all age groups as low surgical risk
patients undergoing routine abdominal surgery all have about the same





TABLE XV. Decision Tree Probability Descriptions
Code Probability Description
A - probability that basic tests are positive given that
the patient has no secondary symptoms
B - probability that auxiliary tests are positive given
that basic tests are positive
C - probability that surgery cures high blood pressure
given that the auxiliary tests are positive
D - probability that drugs control high blood pressure and
that the drugs do not have unacceptable side-effects
E - probability of death given that surgery is conducted
F - probability that the patient continues drugs given that




TABLE XVI. Judgmental Probabilities
Diastolic. blood pressure 90 - 120 mm Hg
Age (years) < 35 35-50 >50
Sex (M=male
JJ
F= female) M F M F M F
CA . 0005 .0005 o0005 .0005 .0005 .0005
CS .0004 .0004 .0004 .0004 .0004 .0004
A R .04 .04 .03 .03 .06 .06
PHEO .005 .005 .0025 .0025 .0025 .0025




.9 .9 .9 .9 .9 .9




.9 .9 .9 .9 .9 .9















.6 .6 .8 .8 .95 .95
R = Renal
PA = Primary Aldosteronism
PHEO = Pheochromocytoma
CA = Coarctation of Aorta
CS = Cushing's Syndrome
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Probability "A" for coarctation of the aorta and dishing' s Syndrome
is very small as secondary symptoms for these internal disorders are
almost always present in a clinical exam (see Table IV). Based on
these low probabilities, coarctation of the aorta and Cushing's
Syndrome branches are removed or "pruned" from the decision tree. As
a result, the only surgically correctable disorders that enter into
the decision analysis are primary aldosteronism, pheochromocytoma, and
renal vascular disease.
Probability "F" is assumed to be a function of age as older people
are usually more concerned about their health and hence, are more
likely to maintain a drug schedule. As a result, it is assumed hyper-
tensive patients less than 35 years of age have a 60 percent chance of
continuing drugs, patients between 35 and 50 years of age have an 80
percent chance of continuing drugs, and patients over 50 years of age
have a 95 percent chance of continuing drugs.
D. SUMMARY OF THE CHAPTER
Sustained diastolic hypertensive diagnosis-treatment alternatives
and their events have been structured in a decision tree. This deci-
sion tree has three strategies. The initial alternative for these
three strategies are: conduct basic tests, administer drugs, and do
nothing. Judgmental probabilities have been obtained for all uncertain
events in the decision tree. An algorithm has been developed for
reducing multiple consequences to a single level of effectiveness when




To obtain outcome preferences, analyst preferences must be
assessed. The analyst must also assess patient preferences. The
algorithm can then be used to develop single measures of effective-
ness. When this is complete, the three problem strategies can be




V. PROBLEM SOLUTION RESULTS
Chapter IV formulated the sustained diastolic hypertension problem.
This chapter analyzes this formulation using three patient decision-
makers. These three decision-makers represent all three age groups and,
as a result, analyze six of the 12 total health profiles.
The chapter is divided into two sections. Section A discusses
decision analysis results. In particular, the results of each decision-
maker analysis is presented, and selected sensitivity analyses are dis-
cussed. Section B describes limitations of the analysis conducted in
Section A and suggests ways in which the solution can be made more
complete.
A. DISCUSSION OF RESULTS
Three patients are used as decision-makers in the decision analysis
of sustained diastolic hypertension: a 30 year old woman, a 45 year old
man, and a 58 year old man. Table XVII gives the author assessments
and the patient assessments for the gambles developed in Table X and
Table XI. The author assessed each age category separately as these
categories each have different health prognoses. The data in Table XVII
are sufficient to calculate a single measure of effectiveness for each
end point of the decision tree. These end point utilities and the
judgmental probabilities can then be used to obtain a single measure
of effectiveness for each of the three, decision tree strategies. This
is done using the "averaging out and folding back" technique described
in Section B of Chapter II.
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TABLE XVIi. Author and Patient Assessments
*






















AU1 .9 .95 .95
AU2 .8 .7 .9
AU3 .9 .95 .95
See Table X and Table XI.
73

The single measure of effectiveness for the three treatment strate-
gies for a 30 year old woman are given in Table XVIII. For a 60 percent
chance that the patient continues drugs, the dominant strategy is to
perform basic tests. This strategy is dominant for both blood pressure
groups. The assumption that 60 percent of the patients continue drugs
is highly questionable. As a result, the analysis is also conducted
using a 90 percent chance that the patient continues drugs. The test
strategy still reigns supreme, indicating women in this age group
should be tested for surgically correctable causes of hypertension even
if there is a high chance a patient will continue drugs.
It seems logical to infer from the above results that the test
strategy is also optimal for men in this age group, since men are
usually less inclined to continue drugs. Furthermore, men tolerate
uncontrolled high blood pressure less well than women making it more
serious when the male patient discontinues drugs.







Strategy Measures of Effectiveness
(Utiles)
continues
drug Test Drugs Nothing
.6
90 - 105 .93683 .93600 .92134
105 - 120 .77011 .76126 .49623
.9
90 - 105 .94620 .94583 .92134
105 - 120 .89851 .89607 .49623
The single measure of effectiveness for the three treatment strate-
gies for the 45 year old man are given in Table XIX. For an 80 percent
chance that the patient continues drugs and for blood pressures between
90 and 105 mm Hg, the patient prefers to be treated with drugs. In
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other words, the inconvenience of taking drugs and the health conse-
quences that result if drugs are not continued are more attractive than
taking a chance on death during surgery. However, when the blood pres-
sure is between 105 and 120 mm Hg, the patient prefers to be given
basic tests. Again an 80 percent chance that the patient continues
drugs is questionable. Therefore, the analysis is also performed for
a 95 percent chance that a patient continues drugs. This analysis is
done only on the higher blood pressure group as the optimal strategy in
the lower blood pressure group is reinforced with this probability
change. The analysis shows the patient still desires to be given basic
tests.
It seems logical to infer that women in this age group in the 90 to
105 mm Hg blood pressure group have the same optimal strategy as men
since women are more likely to continue drugs than men, and women have
a better health prognosis if they discontinue drugs. The optimal
strategy for women in the higher age group cannot be inferred from male
results as the drug strategy is more attractive to women than men.

















.95 105 - 120 .94170 .94125 .49917
The measures of effectiveness for the three treatment strategies
for the 58 year old man are given in Table XX. For the higher blood
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pressure group with a 95 percent chance that drugs are continued, the
optimal strategy is to conduct basic tests. For the lower blood pres-
sure group with a 95 percent chance that drugs are continued, the
optimal strategy is drug treatment. If the chance that a patient con-
tinues drugs is lowered to 80 percent, the lower blood pressure group
still prefers to be treated with drugs.
The chance of death during surgery is assumed to be two percent in
all age groups. However, the definition of "a low surgical risk" is
less well-defined in the older age group. As a result, analyses are
also conducted in the older age group using a four percent chance of
death during surgery. Applying the increased death probability to the
higher blood pressure group with a 95 percent chance drugs are con-
tinued resulted in a change in optimal strategy from basic tests to
drug treatment. Again applying the increased death probability to the
higher blood pressure group but now decreasing the chance drugs are
continued to 80 percent resulted in a change in optimal strategy from
drug treatment to basic test. This implies the older age group is
sensitive to death probability.
The original assumption of low surgical risk and a 95 percent
chance that drugs are continued resulted in the optimal strategy of
drug treatment for the lower blood pressure group and in the optimal
strategy of basic tests for the higher blood pressure group. As in the
case of the 45 year old man, the optimal strategy of drug treatment can
be assumed to hold for women; the optimal strategy of basic test cannot
be assumed to hold for women.
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90 - 105 .98407 .98454 .97912
105 - 120 .96586 .96559 .7
.04 105 - 120 .96486 .96557 .7
.8
.02 90 - 105 .98313 .98358 .97912
.04 105 - 120 .92506 .92358 .7
The decision analysis results for the three preceding cases are
summarized in Table XXI. These results seemed intuitively plausible
to the author. The result that a patient under 35 years of age always
desires basic tests is logical since younger patients: incur a more
severe health prognosis if drugs are discontinued, have a higher chance
of a surgical cure, and are less prone to continue drug treatment. The
result that a 45 year old man in the lower blood pressure group desires
drug treatment is reasonable as this category of sustained diastolic
hypertension has the lowest chance of being surgically correctable.
The outcome of a 58 year old man in the lower blood pressure group
desiring drug treatment is only natural as his condition is almost
normotensive and would not justify the risk of surgery. Finally, the
result of 45 and 58 year old men choosing basic tests if their blood
pressure is between 105 - 120 mm Hg is logical as severe health compli-
cations result if this disease is not controlled. These results give
credence to the way in which the sustained diastolic hypertension prob-
lem is formulated and to the decision analysis technique.
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F = Female M F M F M F
90 - 105
mm Hg BT(I) BT (TR) DT (TR) DT(I) DT (TR) DT(I)
*
105 - 120
mm Hg BT(I) BT (TR) BT (TR) (RU) BT (TR) (RU)
legend: 1. strategies: basic tests = BT
drug treatment = DT
nothing = N
2. result source:
test result = (TR)
inferred result = (I)
result unknown = (RU)
B. RESULT LIMITATIONS
The results given in Section A are not a complete analysis of the
problem. Missing are a larger sample size of patient decision-makers,
the government as a decision-maker, the doctor as a decision-maker, and
more thorough sensitivity analyses. Patient assessments should be done
on men and women for all 12 health profiles, vice the six profiles
directly assessed in this work. Further, redundancy checks should be
conducted by assessing several patients in each age group.
The government as a decision-maker appears highly appropriate in
this case since the government is financing all medical services.
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Recall Equation (5) where
u (x ) = K u (x )ct' g g g
and K represents the decision-maker's concern for government medical
costs. Clearly, K is not zero when the government is the decision-
maker. Inspection of Table VIII shows that the cost components of the
result vector are less significant than the health components. There-
fore, it is possible that decision analysis results, using the govern-
ment as a decision-maker, are the same as the results given in Table
XXI. However, for the analysis to be complete, the government must be
included as a decision-maker.
The doctor as a decision-maker should also be included in the
analysis. The reader is cautioned to note, however, that the doctor as
a decision-maker when practicing medicine, and the doctor as a decision-
maker when being assessed in a decision analysis are not the same. In
the later case, the doctor is only giving his feeling about patient
health factors and government cost factors. Assume that the doctor's
concern for government medical costs is the same as that of the
patient's concern (K =0). Further assume that the doctor feels the
same about patient health consequences as does the patient. These
assumptions are not unreasonable. Then the decision analysis results,
using the doctor as a decision-maker, are the same as results given in
Table XXI.
A critical part of a decision analysis is sensitivity analysis,
where one problem parameter is changed while all other problem para-
meters remain fixed. Sensitivity analyses have been done for the
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following problem parameters: the probability drugs are continued,
and the probability of death during surgery (for one age group). How-
ever, a complete sensitivity analysis requires that all problem para-
meters be tested. Judgmental probabilities should be varied to deter-
mine their effect on the problem. Analyst assessments should be
varied to determine their effect on the problem. These analyses would
isolate the critical problem parameters. Critical problem parameters
can then be scrutinized for credibility.
C. SUMMARY OF THE CHAPTER
The results of the decision analysis for the three patient deci-
sion-makers are intuitive. These results give credence to the hyper-
tensive problem formulation and to the decision analysis technique.
For the decision analysis of specific diagnostic categories in the
public sector where the government is the sole provider, the patient
is viewed as a viable decision-maker. However, a more complete analysis
of the problem formulation requires the government to be used as a
decision-maker and the doctor to be used as a decision-maker. In
addition, a complete sensitivity analysis should be performed.
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VI. SUMMARY AND CONCLUSION
A decision analysis was conducted on the specific diagnostic cate-
gory of hypertension. Specifically, sustained diastolic hypertension
was analyzed as this type of hypertension was common and standard
diagnosis-treatment procedures were lacking.
The problem of analyzing sustained diastolic hypertension was com-
plicated by hypertensive patients having unique health profiles. The
continuum of unique health profiles was broken down into 48 discrete
health profiles. Twelve of these profiles were selected for analysis.
These profiles were low surgical risk male and female patients with:
1. no secondary symptoms,
2. diastolic blood pressure either between 90 and 105 mm Hg or
105 and 120 mm Hg, and
3. one of three age groups: below 35, between 35 to 50, and over
50 years of age.
These discrete profiles represented medical cases where standard
diagnosis -treatment procedures were needed.
There were three treatment options for each of the 12 hypertensive
profiles: treat hypertension with drugs, investigate for surgically
correctable causes of hypertension, or do nothing. The decision analy-
sis of these three options was done in two parts - formulate the
problem and solve the problem. The formulation phase of the decision
analysis was emphasized in this work as it was felt ensuing solutions
to the formulated problem would be routine.
The problem formulation phase of the decision analysis consisted
of structuring the. problem, obtaining judgmental probabilities, and
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establishing preferences of outcomes. The problem was structured by
chronologically arranging diagnosis-treatment alternatives and their
possible events. This resulted in three possible treatment strategies,
one for each treatment option. These strategies were to conduct
laboratory tests, administer drugs, or do nothing. Judgmental probabi-
lities were assigned to the uncertain events identified in the problem
structure. The sources for these probabilities were selected medical
physicians and medical statistics. The final step in the problem for-
mulation consisted of applying multidimensional utility theory to the
possible outcomes in order to reduce multiple outcomes to a single
measure of effectiveness.
In the solution phase of the decision analysis, decision-makers
made trade-offs among possible outcomes. These trade-offs were then
put into the problem formulation to obtain a single measure of effec-
tiveness for each of the three treatment strategies.
Three parties of decision-makers had interest in decision outcomes.
These decision-makers were the patient, the doctor, and the outside
provider (i.e., the government). To limit the solution phase of the
decision analysis, this paper solved the problem using only the patient
as a decision-maker. The patient was viewed as a viable party to make
trade-offs among possible outcomes.
The decision analysis was conducted using three patients that
represented six of the 12 total health profiles. These analyses were
conducted in the environment of a military installation where the
government was the sole provider. Decision analysis results from these
three patients indicated whether a patient desired to be tested, put on
drugs, or not treated. Results obtained were intuitive appealing,
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giving credence to the problem formulation and solution technique.
Results were compromised by three factors:
1. limited sample size of patient decision-makers,
2. use of patients only as decision-makers, and
3. limited sensitivity analysis.
A comprehensive analysis of the hypertension problem as it has been
formulated requires additional efforts in the above areas.
To conclude, decision analysis was shown to be an effective means
of obtaining substantive diagnosis-treatment procedures in specific
diagnostic categories. Uncertain events in the medical decision pro-
cess were exposed. As a result, professional expertise could be
brought to bear on the probable occurrence of these events. Possible
outcomes of various diagnosis-treatment procedures were identified.
Rational trade-offs could then be made among these outcomes. This
recognition of critical problem elements and integration of professional
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